axitinib,sunitinib,avelumab,everolimus,pembrolizumab,cabozantinib,nivolumab,ipilimumab,Lenvatinib
merck,novartis,bms,pfizer,nordic group,eisai
['check,mate,214', 'rcc,(-irccs),(-srcc),(-urcc)', 'al 101', 'renal,(-adrenal)', 'key,note,426', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'javelin,renal,101', 'check,mate,9er', 'probe', 'check,mate,025', 'nivo', 'nordic']
in the final session of #gu23, cites the diverse outcomes across series with surgery for #kidneycancer following io. terrific, comprehensive overview. ultimately an answer will hopefully come from #probe, led by &amp; ! 
@cityofhope & @cityofhopeoc prof w focus on #kidneycancer, #prostatecancer, #bladdercancer & 90s rock. RTs not endorsements. COI: https://t.co/L7ihnCjLz5